Sven Golfier

3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions

Carsten Wenzel, Björn Riefke, Stephan Gründemann et al. · Experimental Cell Research · 2014 · 253 citations · Full text

Medicine, Oncology, Pharmacology +16

Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

Sven Golfier, Charlotte Kopitz, Antje Kahnert et al. · Molecular Cancer Therapeutics · 2014 · 253 citations

Medicine, Oncology, Pharmacology +17

The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models

Antje M. Wengner, Gerhard Siemeister, Ulrich Lücking et al. · Molecular Cancer Therapeutics · 2019 · 210 citations

Medicine, Molecular Biology, Oncology +17

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

Martin A. Sieber, Philipp Lengsfeld, Thomas Frenzel et al. · European Radiology · 2008 · 204 citations · Full text

Medicine, Pathology, Pharmacology +16

Sphingosine‐1‐phospate receptor 4 (S1P ₄ ) deficiency profoundly affects dendritic cell function and T _H 17‐cell differentiation in a murine model

Tobias Schulze, Sven Golfier, Christoph Tabeling et al. · The FASEB Journal · 2011 · 112 citations

Life Sciences, Cell Biology, Immunology +17